It won't because there isn't any pent up demand for this stock and any buying will be from small time flipping yahoos from here and other penny stock boards. The real moves are done with big money coming from hedges, funds, institutions and those fellas don't partake in buying stinky pinkies.
And you might want to revisit Biomatrix's business strategy. The company's ultimate goal is to sell off anything after it has successful P1 trials.
News 
Market Data 
Discover 
AI
